This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2013-2016
Title: Frank M Nedza: Innovator in Pharmaceutical Chemistry
Introduction
Frank M Nedza is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on the development of innovative compounds that have potential therapeutic applications.
Latest Patents
Frank M Nedza's latest patents include the invention of hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. This invention provides novel derivatives that may enhance the efficacy of existing treatments. The detailed description of these compounds highlights their potential benefits in medical applications.
Career Highlights
Throughout his career, Frank has worked with prominent companies such as Incyte Corporation and Incyte Holdings Corporation. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.
Collaborations
Frank has collaborated with talented individuals in his field, including coworkers James David Rodgers and Adam Shilling. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Frank M Nedza is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of valuable compounds. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile